ArticleJournal of clinical immunology2024

Patients with STAT1 Gain-of-function Mutations Display Increased Apoptosis which is Reversed by the JAK Inhibitor Ruxolitinib.

Laura Dotta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.